1. Home
  2. VST vs TAK Comparison

VST vs TAK Comparison

Compare VST & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vistra Corp.

VST

Vistra Corp.

N/A

Current Price

$159.01

Market Cap

55.1B

Sector

Utilities

ML Signal

N/A

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

HOLD

Current Price

$16.56

Market Cap

52.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VST
TAK
Founded
1882
1781
Country
United States
Japan
Employees
N/A
47455
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.1B
52.4B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
VST
TAK
Price
$159.01
$16.56
Analyst Decision
Buy
Analyst Count
11
0
Target Price
$234.09
N/A
AVG Volume (30 Days)
4.0M
2.7M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
0.59%
3.24%
EPS Growth
N/A
N/A
EPS
2.87
N/A
Revenue
$17,738,000,000.00
N/A
Revenue This Year
$30.97
$0.16
Revenue Next Year
$9.19
$1.22
P/E Ratio
$55.03
$41.25
Revenue Growth
2.98
N/A
52 Week Low
$132.66
$12.99
52 Week High
$219.82
$18.90

Technical Indicators

Market Signals
Indicator
VST
TAK
Relative Strength Index (RSI) N/A 57.91
Support Level N/A $16.24
Resistance Level N/A $16.92
Average True Range (ATR) 0.00 0.21
MACD 0.00 0.12
Stochastic Oscillator 0.00 67.92

Price Performance

Historical Comparison
VST
TAK

About VST Vistra Corp.

Vistra Corp. is one of the largest power producers and retail energy providers in the US. It owns 44 gigawatts of generation capacity, including natural gas (27 GW), nuclear (6.5 GW), coal (8.7 GW), and solar and battery storage (1.3 GW). The Cogentrix acquisition will add 5.5 GW of gas generation. Vistra's retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: